rabeprazole sodium delayed-release

Sarras Health, LLC🇺🇸 United States

FDA Page

Effective Date: Dec 29, 2020
Approval ID: 5b1b1530-abc8-487a-b673-2b35cbf14e0c
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE CAPSULES. Rabeprazole Sodium Delayed-Release Capsules (Sprinkle), for oral useInitial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.